BIVALIRUDIN WITH PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS COMPARED TO HEPARIN WITH PLANNED OR PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: NETWORK META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

被引：0
|
作者：
Patel, Tarpan R. [1 ]
Ivanov, Alexander [1 ]
Sacchi, Terrence [1 ]
Heitner, John [1 ]
Brener, Sorin [1 ]
机构：
[1] New York Methodist Hosp, Brooklyn, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30200-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1174-115
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial
    Lincoff, AM
    Bittl, JA
    Harrington, RA
    Feit, F
    Kleiman, NS
    Jackman, JD
    Sarembock, IJ
    Cohen, DJ
    Spriggs, D
    Ebrahimi, R
    Keren, G
    Carr, J
    Cohen, EA
    Betriu, A
    Desmet, W
    Kereiakes, DJ
    Rutsch, W
    Wilcox, RG
    de Feyter, PJ
    Vahanian, A
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (07): : 853 - 863
  • [2] Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous' coronary intervention
    Robertson, Jason O.
    Lincoff, A. Michael
    Wolski, Kathy
    Topol, Eric J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (12): : 1679 - 1684
  • [3] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [4] Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?
    Doggrell, S
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1431 - 1433
  • [5] Efficacy and safety of bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized trials
    Jiang, Long
    Cheng, Xiaoshu
    Yang, Renqiang
    Hu, Lijuan
    Fan, Yingli
    Zhan, Rui
    [J]. CARDIOLOGY, 2013, 126 : 135 - 136
  • [6] Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
    Li, Senjie
    Lv, Dongqing
    Liu, Caihong
    Jia, Yongping
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [7] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Uzoma N. Ibebuogu
    Oluwaseyi Bolorunduro
    Smith Giri
    Sam Dagogo-Jack
    Blake G. Smith
    Saibal Kar
    Guy L. Reed
    [J]. American Journal of Cardiovascular Drugs, 2015, 15 : 275 - 285
  • [8] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials
    Zhu, Jianbing
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C132 - C132
  • [9] Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors
    Abtahian, Farhad
    Waldo, Stephen
    Jang, Ik-Kyung
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (03) : 390 - 396
  • [10] EFFICACY AND SAFETY OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMISED TRIALS
    JiangLong
    Yang, Ren-Qiang
    Fan, Ying-Li
    Zhan, Rui
    Hu, Li-Juan
    Cheng, Xiao-Shu
    [J]. HEART, 2013, 99 : E163 - E163
12345